Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission: A case report

RATIONALE: Antimelanoma differentiation-associated gene 5 antibody (anti-MDA5 Ab)-positive clinically amyopathic dermatomyositis (cADM) is frequently complicated with interstitial lung disease (ILD) and has a poor prognosis. Although the short-term prognosis of anti-MDA5 Ab-positive cADM is poor, it...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicine (Baltimore)
Asıl Yazarlar: Ishikawa, Yuichi, Kasuya, Tadamichi, Fujiwara, Michio, Kita, Yasuhiko
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2020
Konular:
6900
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7489601/
https://ncbi.nlm.nih.gov/pubmed/32925726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000021943
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller